Assistant Professor of Pediatrics, Boston Children's Hospital
Allergy & Immunology
Dr. Andrew J. Macginnitie, MD
|
|
Give Review
Andrew Macginnitie is an expert in the field of Allergy & Immunology. He attended University of Chicago Pritzker School of Medicine. University of Chicago Pritzker School of Medicine is ranked 10/19 in Research/PrimaryCare. He received 1 awards: "Regional Top Doctor". Dr. Andrew J. Macginnitie is also a published MD. He has 24 publication published. The most recent publication is: A cytidine deaminase expressed in the post-infective L3 stage of the filarial nematode, Brugia pahangi, has a novel RNA-binding activity.
Publications
- Use of ecallantide in pediatric hereditary angioedema.
- Outcomes after ecallantide treatment of laryngeal hereditary angioedema attacks.
- Analysis of hereditary angioedema attacks requiring a second dose of ecallantide.
- Efficacy and safety of ecallantide in treatment of recurrent attacks of hereditary angioedema: Open-label continuation study.
- Ecallantide for treatment of acute hereditary angioedema attacks: Analysis of efficacy by patient characteristics.
- Indoor allergen sensitization and the risk of asthma and eczema in children in Pittsburgh.
- 11q terminal deletion disorder and common variable immunodeficiency.
- Chronic granulomatous disease in an adolescent with recurrent impetigo and cholecystectomy.
- X-linked lymphoproliferative disease in an EBV-negative patient presenting with pancytopenia.
- X-linked lymphoproliferative disease: genetic lesions and clinical consequences.
- Infant with unusual food reactions.
- Successful use of ecallantide to treat a hereditary angioedema attack after failure of C1 inhibitor prophylaxis.
- Clinical characteristics of pediatric patients evaluated for primary immunodeficiency.
- Higher-ovalbumin-content influenza vaccines are well tolerated in children with egg allergy.
- In utero anaphylaxis.
- Exaggerated IL-17 response to epicutaneous sensitization mediates airway inflammation in the absence of IL-4 and IL-13.
- Psoriasis upregulated phorbolin-1 shares structural but not functional similarity to the mRNA-editing protein apobec-1.
- A cytidine deaminase expressed in the post-infective L3 stage of the filarial nematode, Brugia pahangi, has a novel RNA-binding activity.
- The binding of apobec-1 to mammalian apo B RNA is stabilized by the presence of complementation factors which are required for post-transcriptional editing.
- Mutagenesis of apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, reveals distinct domains that mediate cytosine nucleoside deamina...
- apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, is a novel RNA-binding protein.
- Apolipoprotein B messenger RNA editing: insights into the molecular regulation of post-transcriptional cytidine deamination.
- Management of an anaphylactoid reaction to methotrexate with a stepwise graded challenge.
Schools
U Of Chgo Div Of Bio Sci Pritzker Sch Of Med
Doctors Specialties
- Pediatrics
- Allergy
- Immunology
Accepted Insurances
Awards
- Regional Top Doctor
Education
-
Boston Children's Hospital -
University of Chicago Pritzker School of Medicine
Hospital
-
Boston Children's Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Javed Sheikh, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel L. Hamilos, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Richard A. Moscicki, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kimberly G. Blumenthal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anne E. Goldfeld, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Alexia V. Harrist, MD |
|
|
Dr. Amy L. Ryan, MD |
|
|
Dr. Allon Beck, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Francisco A. Bonilla, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. David S. Leslie, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christine J. Johannes, MD |